Patent · US Active

Low-dose doxepin formulations and methods of making and using the same

US9907780B2 · kind B2 · utility

1Cited by
48References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 30, 2016
Grant dateMar 6, 2018
Priority date—
Expiry dateDec 30, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.